: Sanofi $SNY filed a lawsuit against Merck�s $MRK international division for alleged infringing its patent rights. Sanofi said that Merck�s international division violated as many as ten of its patents, which include one of its blockbuster diabetes treatment, Lantus and its insulin delivery devices soloSTAR.